VEGF and FGF-8 in Prostate Cancer
Author Information
Author(s): West A F, O'Donnell M, Charlton R G, Neal D E, Leung H Y
Primary Institution: Prostate Research Group, Department of Surgery, The Medical School, University of Newcastle
Hypothesis
The study investigates the correlation of vascular endothelial growth factor (VEGF) expression with fibroblast growth factor-8 (FGF-8) expression and clinico-pathologic parameters in human prostate cancer.
Conclusion
The study found a significant correlation between VEGF and FGF-8 expression in prostate cancer, which is associated with clinical parameters and survival rates.
Supporting Evidence
- VEGF was detected in malignant cells in 45 out of 67 cases.
- Positive VEGF immunoreactivity in benign glands was restricted to basal epithelium.
- VEGF expression correlated with increased serum PSA levels.
- Stromal VEGF and tumour stage were significant independent predictors of survival.
Takeaway
This study looked at how two proteins, VEGF and FGF-8, are related in prostate cancer and found that they can help predict how serious the cancer is.
Methodology
The study used immunohistochemistry to analyze VEGF and FGF-8 expression in prostate cancer samples.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website